Drug-labels.com

Zyloprim 100: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
100 mg, 200 mg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - Zyloprim 100

ABOUT THIS MEDICATION

What the medication is used for:

ZYLOPRIM® (allopurinol) is used for:

$ treatment of gout (a painful inflammation primarily of the

big toe),

$ treatment of kidney problems due to high uric acid levels $ treatment or prevention of uric acid deposits in the tissues

or kidneys due to high levels of uric acid in the blood, which may also be caused by certain cancer treatments. $ prevention of uric acid stones or gravel and kidney stone

in patients with high levels of uric acid in blood or urine.

What it does:

ZYLOPRIM® works by reducing the production of uric acid in the body.

When it should not be used:

ZYLOPRIM® should not be used:

$ if you are allergic to the active ingredient allopurinol or

had a previous serious allergic reaction to allopurinol or any ingredient in ZYLOPRIM® (See what the medicinal ingredient is and what the nonmedicinal ingredients are sections).

$ if you are breastfeeding.

$ if you are less than 18 years old (except in children with

hyperuricemia (a high level of uric acid in the blood secondary to cancerous growths).

What the medicinal ingredient is:

The medicinal ingredient in ZYLOPRIM® is allopurinol.

What the important nonmedicinal ingredients are:

ZYLOPRIM® contains the following nonmedicinal ingredients: starch, lactose, magnesium stearate, povidone. In addition, the 300 mg tablets contain FD&C Yellow #6 Lake.

What dosage forms it comes in:

ZYLOPRIM® is available as 100 mg, 200 mg and 300 mg tablets.

WARNINGS AND PRECAUTIONS

BEFORE you use ZYLOPRIM® talk to your doctor or pharmacist if:

  • you are allergic to allopurinol or any other medications.
  • you have or have ever had kidney or liver disease or heart disease.
  • you are pregnant, plan to become pregnant, or are breastfeeding.

Gout attacks may occur at the start of treatment. Do not drive or operate machinery if feeling sleepy or drowsy.

INTERACTIONS WITH THIS MEDICATION

Tell your doctor what prescription and non-prescription medications, vitamins, nutritional supplements and herbal products you are taking, especially:

chemotherapy agents

coumarin, anticoagulants

amoxicillin/ampicillin

chlorpropamide

didanosine

phenytoin

theophylline

salicylates and uricosurics

probenecid

cyclosporin

vidarabine

PROPER USE OF THIS MEDICATION

Usual dose:

Adults

General:

The total daily requirement should be divided into 1 to 3 doses. Daily doses up to and including 300 mg ZYLOPRIM® may be taken once a day after a meal. You should drink plenty of fluids while taking ZYLOPRIM®.

Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take ZYLOPRIM® exactly as directed. Do not take more or less than prescribed by your doctor.

Overdose:

You should immediately contact either your doctor, your hospital emergency department or the nearest poison control centre.

Symptoms and signs of overdosage include nausea, vomiting, diarrhea and dizziness.

IMPORTANT: PLEASE READ

DCTM/219/521/2006-07-04-131-pm-pristine-ZYLOPRIM.doc

Page 19 of 19 Missed Dose:

If you forget to take your medicine, take it as soon as you

remember. However, if it is almost time for the next dose,

skip the missed dose and continue your regular dosing

schedule. Do not take a double dose to make up for a missed

dose.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
FrequencySide effect/ SymptomTalk with your doctor or pharmacist

Stop taking drug and call your doctor

or

pharmacist

Only if

severe

In all cases
Common

Skin rash and hypersensitivity reactions

(serious allergic reactions)

99
Uncommon

Drowsiness, diarrhea,

abdominal pain, nausea,

vomiting.

99

This is not a complete list of side effects. For any unexpected effects while taking ZYLOPRIM®, contact your doctor or pharmacist.

Gout attacks may occur at the start of treatment

HOW TO STORE IT

ZYLOPRIM® should be stored between 15 and 30°C, out of the reach of children.

REPORTING SUSPECTED SIDE EFFECTS

To monitor drug safety, Health Canada collects information on serious and unexpected effects of drugs . If you suspect you have had a serious or unexpected reaction to this drug you may notify Health Canada by:

toll-free telephone: 866-234-2345 toll-free fax 866-678-6789

By email: cadrmp@hc-sc.gc.ca

By regular mail:

National AR Centre

Marketed Health Products Safety and Effectiveness Information Division

Marketed Health Products Directorate

Tunney’s Pasture, AL 0701C

Ottawa ON K1A 0K9

NOTE: Before contacting Health Canada, you should contact your physician or pharmacist.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals can be found by contacting the sponsor, GlaxoSmithKline Inc.

7333 Mississauga Road

Mississauga, Ontario

L5N 6L4

1-800-387-7374

Last revised: July 05, 2006

© 2006 GlaxoSmithKline Inc. All Rights Reserved

®ZYLOPRIM is a registered trademark, used under license by GlaxoSmithKline Inc.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 00004588

Revision date stated in the text: July 5, 2006

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Zyloprim 100

Rx or OTC
Prescription (Rx)?
DIN 00004588, 00506370
Schedule(s) PRESCRIPTION
Active ingredient(s) Allopurinol
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. M Musculo-skeletal system drugs
    1. M04 Antigout preparations
      1. M04A Antigout preparations
        1. M04AA Preparations inhibiting uric acid production
          1. M04AA01 Allopurinol
Company GLAXOSMITHKLINE INC
Current status Cancelled Post Market
Strengths and forms
DIN Strength Dosage form(s) Current status
00004588 100 MG Tablet Cancelled Post Market November 21, 2006
00506370 200 MG Tablet Cancelled Post Market April 4, 2007

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.